# Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα

> **NCT02620189** · — · COMPLETED · sponsor: **Queen Mary University of London** · enrollment: 60 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Anti-TNF Biologics Therapy

## Key facts

- **NCT ID:** NCT02620189
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2017-05-24
- **Final completion:** 2017-05-24
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02620189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02620189, "Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02620189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*